Insmed Inc at Goldman Sachs Global Healthcare Conference Transcript
Okay. Good morning, everyone. Welcome to day 3 of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I work on the biotech research efforts here at the firm.
Before I introduce Insmed and Will Lewis, I just have to read an obligatory disclaimer statement here, so bear with me.
We are required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are also available in our most recent reports available to you as clients on the firm's portal. Disclosures and updates to those disclosures are also available by ticker on the firm's public website. And finally, the views stated by non-Goldman Sachs personnel do not necessarily reflect those of Goldman Sachs.
So with that, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
